About lenalidomide
Immunomodulatory anticancer medicine
Used for
- Multiple myeloma, usually with other medicines
- Myelodysplastic syndromes with certain chromosome changes
- Mantle cell lymphoma after prior treatment
- Follicular lymphoma after prior treatment
Usual adult dose
Often 25 mg by mouth daily on days 1–21 of a 28-day cycle for multiple myeloma; doses vary by condition and kidney function.
Common side effects
- Low blood cell counts and increased infection risk
- Blood clots
- Diarrhea, constipation, or nausea
- Fatigue, rash, or itching
Important warnings
- Can cause severe birth defects; strict pregnancy-prevention measures are required.
- May cause dangerously low blood counts; regular blood tests are required.
- Blood clots can occur, especially with multiple myeloma treatment combinations.
- Can increase risks of severe infections and certain other cancers.
Pregnancy
Must not be used during pregnancy; can cause severe birth defects. Pregnancy-prevention requirements apply.
Breastfeeding
Breastfeeding is not recommended during treatment.
Interactions
- Other medicines that increase clot risk may raise the chance of blood clots.
- Erythropoietin-stimulating medicines may increase blood clot risk.
- Digoxin levels may rise; monitoring may be needed.
- Warfarin effects may change; monitoring may be needed.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.